CD38 is a potential treatment target in lymphoma patients concurrently infected with human immunodeficiency virus

Trine Engelbrecht Hybel, Maja Ølholm Vase, Kristina Lystlund Lauridsen, Marie Beck Enemark, Michael Boe Møller, Court Pedersen, Gitte Pedersen, Stephen Hamilton-Dutoit, Niels Obel, Carsten Schade Larsen, Francesco d'Amore, Maja Ludvigsen*

*Corresponding author for this work

Research output: Contribution to journalComment/debateResearchpeer-review

Original languageEnglish
JournalLeukemia and Lymphoma
Volume63
Issue number6
Pages (from-to)1479-1483
Number of pages5
ISSN1042-8194
DOIs
Publication statusPublished - 2022

Keywords

  • ADP-ribosyl Cyclase 1
  • HIV
  • HIV Infections/complications
  • Humans
  • Lymphoma/complications

Cite this